EQUILLIUM, INC. Operating Expenses
EQUILLIUM, INC. (EQ) reported Operating Expenses of $5.16 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-13
- EQUILLIUM, INC. operating expenses for the quarter ending 2026-06-30 was $5.16M, a 17.23% decline year-over-year.
- EQUILLIUM, INC. operating expenses for the quarter ending 2026-03-31 was $5.61M, a 36.75% decline year-over-year.
- EQUILLIUM, INC. operating expenses for the quarter ending 2025-12-31 was $3.96M, a 56.41% decline year-over-year.
- EQUILLIUM, INC. operating expenses for the quarter ending 2025-09-30 was $4.58M, a 64.37% decline year-over-year.
- EQUILLIUM, INC. operating expenses for fiscal 2025 was $23.63M, a 52.12% decline from fiscal 2024.
- EQUILLIUM, INC. operating expenses for fiscal 2024 was $49.36M, a 2.45% decline from fiscal 2023.
- EQUILLIUM, INC. operating expenses for fiscal 2023 was $50.61M, a 34.98% decline from fiscal 2022.
- EQUILLIUM, INC. operating expenses for fiscal 2022 was $77.83M, a 105.99% increase from fiscal 2021.
| Period end | Operating Expenses 0 month | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 7 month | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 10 month | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $5.16M 10-Q · filed 2026-08-13 | $10.77M 10-Q · filed 2026-08-13 | $14.73M derived: sum of 3 quarters · filed 2026-08-13 | $19.30M derived: sum of 4 quarters · filed 2026-08-13 | ||||||
| 2026-03-31 | $5.61M 10-Q · filed 2026-05-13 | $9.57M derived: sum of 2 quarters · filed 2026-05-13 | $14.15M derived: sum of 3 quarters · filed 2026-05-13 | $20.38M derived: sum of 4 quarters · filed 2026-08-13 | ||||||
| 2025-12-31 | $3.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $8.54M derived: sum of 2 quarters · filed 2026-03-25 | $14.77M derived: sum of 3 quarters · filed 2026-08-13 | $23.63M 10-K · filed 2026-03-25 | ||||||
| 2025-09-30 | $4.58M 10-Q · filed 2025-11-13 | $10.80M derived: sum of 2 quarters · filed 2026-08-13 | $19.67M 10-Q · filed 2025-11-13 | $28.76M derived: sum of 4 quarters · filed 2026-08-13 | ||||||
| 2025-06-30 | $6.23M 10-Q · filed 2026-08-13 | $15.10M 10-Q · filed 2026-08-13 | $24.19M derived: sum of 3 quarters · filed 2026-08-13 | $37.03M derived: sum of 4 quarters · filed 2026-08-13 | ||||||
| 2025-03-31 | $8.87M 10-Q · filed 2026-05-13 | $17.96M derived: sum of 2 quarters · filed 2026-05-13 | $30.80M derived: sum of 3 quarters · filed 2026-05-13 | $44.75M derived: sum of 4 quarters · filed 2026-05-13 | ||||||
| 2024-12-31 | $9.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $21.93M derived: sum of 2 quarters · filed 2026-03-25 | $35.88M derived: sum of 3 quarters · filed 2026-03-25 | $49.36M 10-K · filed 2026-03-25 | ||||||
| 2024-09-30 | $12.84M 10-Q · filed 2025-11-13 | $26.79M derived: sum of 2 quarters · filed 2025-11-13 | $40.27M 10-Q · filed 2025-11-13 | $52.68M derived: sum of 4 quarters · filed 2025-11-13 | ||||||
| 2024-06-30 | $13.95M 10-Q · filed 2025-08-14 | $27.43M 10-Q · filed 2025-08-14 | $39.84M derived: sum of 3 quarters · filed 2025-08-14 | $52.34M derived: sum of 4 quarters · filed 2025-08-14 | ||||||
| 2024-03-31 | $13.48M 10-Q · filed 2025-05-14 | $25.89M derived: sum of 2 quarters · filed 2025-05-14 | $38.38M derived: sum of 3 quarters · filed 2025-05-14 | $51.10M derived: sum of 4 quarters · filed 2025-05-14 | ||||||
| 2023-12-31 | $12.41M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $24.90M derived: sum of 2 quarters · filed 2025-03-27 | $37.62M derived: sum of 3 quarters · filed 2025-03-27 | $50.61M 10-K · filed 2025-03-27 | ||||||
| 2023-09-30 | $12.49M 10-Q · filed 2024-11-13 | $25.21M derived: sum of 2 quarters · filed 2024-11-13 | $38.20M 10-Q · filed 2024-11-13 | $51.91M derived: sum of 4 quarters · filed 2024-11-13 | ||||||
| 2023-06-30 | $12.71M 10-Q · filed 2024-08-08 | $25.70M 10-Q · filed 2024-08-08 | $39.42M derived: sum of 3 quarters · filed 2024-08-08 | $52.66M derived: sum of 4 quarters · filed 2024-08-08 | ||||||
| 2023-03-31 | $12.99M 10-Q · filed 2024-05-09 | $26.70M derived: sum of 2 quarters · filed 2024-05-09 | $39.94M derived: sum of 3 quarters · filed 2024-05-09 | $53.49M derived: sum of 4 quarters · filed 2024-05-09 | ||||||
| 2022-12-31 | $13.72M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $26.95M derived: sum of 2 quarters · filed 2024-03-25 | $40.51M derived: sum of 3 quarters · filed 2024-03-25 | $77.83M 10-K · filed 2024-03-25 | ||||||
| 2022-09-30 | $13.24M 10-Q · filed 2023-11-08 | $26.79M derived: sum of 2 quarters · filed 2023-11-08 | $64.12M 10-Q · filed 2023-11-08 | $74.50M derived: sum of 4 quarters · filed 2023-11-08 | ||||||
| 2022-06-30 | $13.55M 10-Q · filed 2023-08-09 | $50.88M 10-Q · filed 2023-08-09 | $61.27M derived: sum of 3 quarters · filed 2023-08-09 | $71.13M derived: sum of 4 quarters · filed 2023-08-09 | ||||||
| 2022-03-31 | $37.33M 10-Q · filed 2023-05-11 | $47.72M derived: sum of 2 quarters · filed 2023-05-11 | $57.58M derived: sum of 3 quarters · filed 2023-05-11 | $66.42M derived: sum of 4 quarters · filed 2023-05-11 | ||||||
| 2021-12-31 | $10.39M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $20.25M derived: sum of 2 quarters · filed 2023-03-23 | $29.09M derived: sum of 3 quarters · filed 2023-03-23 | $37.79M 10-K · filed 2023-03-23 | ||||||
| 2021-09-30 | $9.86M 10-Q · filed 2022-11-14 | $18.70M derived: sum of 2 quarters · filed 2022-11-14 | $27.40M 10-Q · filed 2022-11-14 | $36.37M derived: sum of 4 quarters · filed 2022-11-14 | ||||||
| 2021-06-30 | $8.84M 10-Q · filed 2022-08-15 | $17.54M 10-Q · filed 2022-08-15 | $26.51M derived: sum of 3 quarters · filed 2022-08-15 | $33.02M derived: sum of 4 quarters · filed 2022-08-15 | ||||||
| 2021-03-31 | $8.70M 10-Q · filed 2022-05-12 | $17.66M derived: sum of 2 quarters · filed 2022-05-12 | $24.18M derived: sum of 3 quarters · filed 2022-05-12 | $30.79M derived: sum of 4 quarters · filed 2022-05-12 | ||||||
| 2020-12-31 | $8.97M 10-K · filed 2021-03-24 | $15.49M derived: sum of 2 quarters · filed 2021-11-10 | $22.10M derived: sum of 3 quarters · filed 2021-11-10 | $29.55M 10-K · filed 2022-03-23 | ||||||
| 2020-09-30 | $6.52M 10-Q · filed 2021-11-10 | $13.13M derived: sum of 2 quarters · filed 2021-11-10 | $20.58M 10-Q · filed 2021-11-10 | $28.19M derived: sum of 4 quarters · filed 2021-11-10 | ||||||
| 2020-06-30 | $6.61M 10-Q · filed 2021-08-10 | $14.06M 10-Q · filed 2021-08-10 | $21.68M derived: sum of 3 quarters · filed 2021-08-10 | $28.00M derived: sum of 4 quarters · filed 2021-08-10 | ||||||
| 2020-03-31 | $7.45M 10-Q · filed 2021-05-13 | $15.07M derived: sum of 2 quarters · filed 2021-05-13 | $21.39M derived: sum of 3 quarters · filed 2021-05-13 | $27.83M derived: sum of 4 quarters · filed 2021-05-13 | ||||||
| 2019-12-31 | $7.62M 10-K · filed 2021-03-24 | $13.94M derived: sum of 2 quarters · filed 2021-03-24 | $20.38M derived: sum of 3 quarters · filed 2021-03-24 | $26.73M 10-K · filed 2021-03-24 | ||||||
| 2019-09-30 | $6.32M 10-K · filed 2021-03-24 | $12.76M derived: sum of 2 quarters · filed 2021-03-24 | $19.11M 10-Q · filed 2020-11-10 | $23.34M derived: sum of 4 quarters · filed 2021-03-24 | ||||||
| 2019-06-30 | $6.44M 10-K · filed 2021-03-24 | $12.79M 10-Q · filed 2020-08-12 | $17.02M derived: sum of 3 quarters · filed 2021-03-24 | $19.24M derived: sum of 4 quarters · filed 2021-03-24 | ||||||
| 2019-03-31 | $6.35M 10-K · filed 2021-03-24 | $10.58M derived: sum of 2 quarters · filed 2021-03-24 | $12.80M derived: sum of 3 quarters · filed 2021-03-24 | $13.93M derived: sum of 4 quarters · filed 2021-03-24 | ||||||
| 2018-12-31 | $4.23M 10-K · filed 2020-03-26 | -$4.23M 10-K · filed 2019-03-27 | $6.45M derived: sum of 2 quarters · filed 2020-03-26 | $7.58M derived: sum of 3 quarters · filed 2020-03-26 | $8.62M 10-K · filed 2020-03-26 | $8.62M 10-K · filed 2019-03-27 | ||||
| 2018-09-30 | $2.23M 10-K · filed 2020-03-26 | $2.23M 10-Q · filed 2018-11-15 | $3.35M derived: sum of 2 quarters · filed 2020-03-26 | $4.39M 10-Q · filed 2019-11-12 | $4.39M 10-Q · filed 2018-11-15 | $3.75M derived: sum of 4 quarters · filed 2020-03-26 | ||||
| 2018-06-30 | $1.13M 10-K · filed 2020-03-26 | -$1.13M 10-K · filed 2019-03-27 | $2.16M 10-Q · filed 2019-08-12 | $1.52M derived: sum of 3 quarters · filed 2020-03-26 | $1.44M derived: sum of 4 quarters · filed 2020-03-26 | |||||
| 2018-03-31 | $1.04M 10-K · filed 2020-03-26 | -$1.04M 10-K · filed 2019-03-27 | $397.20K derived: sum of 2 quarters · filed 2020-03-26 | $313.49K derived: sum of 3 quarters · filed 2020-03-26 | -$607.85K derived: sum of 4 quarters · filed 2020-03-26 | |||||
| 2017-12-31 | -$639.80K 10-K · filed 2019-03-27 | -$723.51K derived: sum of 2 quarters · filed 2019-03-27 | -$1.64M derived: sum of 3 quarters · filed 2019-03-27 | $1.71M 10-K · filed 2019-03-27 | ||||||
| 2017-09-30 | -$83.71K 10-K · filed 2019-03-27 | $83.71K 10-Q · filed 2018-11-15 | -$1.01M derived: sum of 2 quarters · filed 2019-03-27 | $1.07M 10-Q · filed 2018-11-15 | ||||||
| 2017-06-30 | -$921.34K 10-K · filed 2019-03-27 | |||||||||
| 2017-03-31 | -$67.19K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |